SEC Form 10-Q filed by Enact Holdings Inc.

4 - Enact Holdings, Inc. (0001823529) (Issuer)

4 - Enact Holdings, Inc. (0001823529) (Issuer)

4 - Enact Holdings, Inc. (0001823529) (Issuer)

Strategic Highlights Continued progress on the LTC1 multi-year rate action plan (MYRAP) with $124M of gross incremental premium approvals; approximately $30B estimated net present value achieved from in-force rate actions (IFAs) since 2012 Expanded the CareScout Quality Network to 49 states through October, covering over 75% of the aged 65-plus Census population in the United States; on track to achieve 80% to 85% coverage by year-end Executed $36M in share repurchases in the quarter; $144M executed year-to-date through October at an average price of $6.29 per share Repurchased $17M in principal of holding company debt at a discount Financial Highlights Net income2 of $85M, or $

GAAP Net Income of $181 million, or $1.15 per diluted shareAdjusted Operating Income of $182 million, or $1.16 per diluted shareReturn on Equity of 14.7% and Adjusted Operating Return on Equity of 14.8%Record Primary insurance in-force of $268 billion, a 2% increase from third quarter 2023PMIERs Sufficiency of 173% or $2,190 millionBook Value Per Share of $32.61 and Book Value Per Share excluding AOCI of $33.27Announces quarterly cash dividend of $0.185 per common share RALEIGH, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the third quarter of 2024. "Our strong third-quarter performance underscores the continued successfu

Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing third quarter results after the market closes on November 6, 2024. A conference call will be held on November 7, 2024, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's November 7 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #1689846. To participate in t

10-Q - Enact Holdings, Inc. (0001823529) (Filer)

8-K - Enact Holdings, Inc. (0001823529) (Filer)

10-Q - Enact Holdings, Inc. (0001823529) (Filer)

UBS analyst Douglas Harter maintains Enact Holdings (NASDAQ:ACT) with a Neutral and raises the price target from $31 to $33.

Enact Holdings (NASDAQ:ACT) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.96 by 8.33 percent. This is a 3.7 percent decrease over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $291.576 million which missed the analyst consensus estimate of $294.116 million by 0.86 percent. This is a 3.79 percent increase over sales of $280.939 million the same period last year.

Enact Holdings, Inc. (NASDAQ:ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors declared a quarterly dividend of $0.185 per common share, an increase of 16% from the prior quarter's dividend. This dividend will be payable on June 13, 2024, to shareholders of record on May 29, 2024. Future dividends will be subject to Board approval. Additionally, Enact announced that its Board of Directors authorized a new share repurchase program under which the company may purchase up to $250 million of its common stock. The new share repurchase authorization is in addition to the company's current $100 million share